Artificial sweeteners produce no glucagon response

January 14, 2014
Artificial sweeteners produce no glucagon response

(HealthDay)—Artificial sweeteners do not produce any changes in glucose metabolism compared to a glass of water, according to a letter published in the December issue of Diabetes Care.

Tongzhi Wu, M.B.B.S., from the University of Adelaide in Australia, and colleagues evaluated whether oral administration of sucralose and acesulfame potassium (AceK) would augment the glucagon-like peptide-1 (GLP-1) response to oral and modulate gastric emptying or glycemia in 10 healthy men (mean age, 33.6 years). Participants were studied on four occasions separated by at least three days, in which they, following an overnight fast, consumed either 240 mL water alone or equivalently sweetened with 52 mg sucralose; 200 mg AceK; or 46 mg sucralose plus 26 mg AceK. Ten minutes later, each drank 75 g of glucose, made up to 300 mL with water and containing 150 mg 13C-acetate. Over 240 minutes, blood glucose, plasma insulin, total GLP-1, and gastric emptying were measured.

The researchers found that , plasma insulin, and total GLP-1 concentrations did not change after either water or sweetened drinks, prior to glucose ingestion; however, following oral glucose, each significantly increased (P < 0.001 for each). There were no differences between the four days with either the 13CO2:12CO2 ratio or the half-emptying time.

"In conclusion, sucralose and AceK, either alone or in combination, have no acute effect on gastric emptying, GLP-1, or glycemic responses after oral glucose in healthy humans," the authors write.

Explore further: Sucralose affects response to oral glucose load in obese

More information: Abstract
Full Text

Related Stories

Sucralose affects response to oral glucose load in obese

July 2, 2013
(HealthDay)—For obese adults who do not use non-nutritive sweetener (NNS), sucralose affects the glycemic and insulin responses to an oral glucose load, according to a study published online April 30 in Diabetes Care.

Novel soy germ pasta improves gastric emptying time

August 14, 2013
(HealthDay)—Pasta enriched with biologically active isoflavone aglycons significantly improves gastric emptying time in patients with type 2 diabetes, according to a pilot study published online July 8 in Diabetes Care.

Diet soda linked to increase in glucagon-like peptide 1 levels

March 22, 2012
(HealthDay) -- Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 (GLP-1) secretion in individuals with type 1 diabetes and healthy controls, but not in those with type 2 diabetes, ...

In diabetes, gastric emptying remains stable over time

August 24, 2012
(HealthDay)—Gastric emptying of solids and liquids and gastrointestinal symptoms remain stable over time in patients with long-term type 1 and type 2 diabetes, according to a study published online Aug. 13 in Diabetes Care.

Gut hormone test predicts individual efficacy of gastric bypass

November 8, 2013
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker ...

Artificial sweeteners may do more than sweeten

May 29, 2013
Researchers at Washington University School of Medicine in St. Louis have found that a popular artificial sweetener can modify how the body handles sugar.

Recommended for you

Alzheimer's drug cuts hallmark inflammation related to metabolic syndrome by 25 percent

July 20, 2017
An existing Alzheimer's medication slashes inflammation and insulin resistance in patients with metabolic syndrome, a potential therapeutic intervention for a highly dangerous condition affecting 30 percent of adults in the ...

Diabetes or its precursor affects 100 million Americans

July 19, 2017
Almost one-third of the US population—100 million people—either has diabetes or its precursor condition, known as pre-diabetes, said a government report Tuesday.

One virus may protect against type 1 diabetes, others may increase risk

July 11, 2017
Doctors can't predict who will develop type 1 diabetes, a chronic autoimmune disease in which the immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring.

Diabetes complications are a risk factor for repeat hospitalizations, study shows

July 7, 2017
For patients with diabetes, one reason for hospitalization and unplanned hospital readmission is severe dysglycemia (uncontrolled hyperglycemia - high blood sugar, or hypoglycemia - low blood sugar), says new research published ...

Researchers identify promising target to protect bone in patients with diabetes

July 7, 2017
Utilizing metabolomics research techniques, NYU Dentistry researchers investigated the underlying biochemical activity and signaling within the bone marrow of hyperglycemic mice with hopes of reducing fracture risks of diabetics

Immune system killer cells increase risk of diabetes

July 6, 2017
More than half of the German population is obese. One effect of obesity is to chronically activate the immune system, placing it under continuous stress. Researchers in Jens Brüning's team at the Max-Planck-Institute for ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.